These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 10573704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Biliary elimination and hepatic disposition of an association of piperacillin and tazobactam: experimental evaluation.
    Brogard JM, Caro-Sampara F, Westphal JF, Blickle JF, Jehl F.
    Drugs Exp Clin Res; 1994; 20(6):247-55. PubMed ID: 7758397
    [Abstract] [Full Text] [Related]

  • 3. Assessment of biliary excretion of piperacillin-tazobactam in humans.
    Westphal JF, Brogard JM, Caro-Sampara F, Adloff M, Blicklé JF, Monteil H, Jehl F.
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1636-40. PubMed ID: 9257733
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients.
    Jehl F, Muller-Serieys C, de Larminat V, Monteil H, Bergogne-Berezin E.
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2780-4. PubMed ID: 7695262
    [Abstract] [Full Text] [Related]

  • 6. Biliary pharmacokinetic profile of piperacillin: experimental data and evaluation in man.
    Brogard JM, Jehl F, Blickle JF, Dorner M, Arnaud JP, Monteil H.
    Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):462-70. PubMed ID: 2272706
    [Abstract] [Full Text] [Related]

  • 7. Penetration of piperacillin/tazobactam (4 g/500 mg) into synovial tissue.
    Boselli E, Breilh D, Debon R, Duflo F, Bel JC, Saux MC, Chassard D, Allaouchiche B.
    J Chemother; 2002 Feb; 14(1):54-8. PubMed ID: 11892900
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Chemotherapy of biliary tract infections (XXIV). Biliary excretion and gallbladder tissue levels of mezlocillin].
    Kobayashi N, Tanimura H, Huang WF, Sekiya T, Takahashi H, Sato T, Yoshida K, Hikasa Y.
    Jpn J Antibiot; 1984 Apr; 37(4):597-604. PubMed ID: 6471380
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Target attainment analysis and optimal sampling designs for population pharmacokinetic study on piperacillin/tazobactam in neonates and young infants.
    Chen Y, Lu J, Dong M, Wu D, Zhu Y, Li Q, Chen C, Li Z.
    Eur J Clin Pharmacol; 2016 Dec; 72(12):1479-1488. PubMed ID: 27644691
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam during high volume haemodiafiltration in patients with septic shock.
    Tamme K, Oselin K, Kipper K, Tasa T, Metsvaht T, Karjagin J, Herodes K, Kern H, Starkopf J.
    Acta Anaesthesiol Scand; 2016 Feb; 60(2):230-40. PubMed ID: 26830215
    [Abstract] [Full Text] [Related]

  • 15. Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.
    Nau R, Kinzig-Schippers M, Sörgel F, Schinschke S, Rössing R, Müller C, Kolenda H, Prange HW.
    Antimicrob Agents Chemother; 1997 May; 41(5):987-91. PubMed ID: 9145857
    [Abstract] [Full Text] [Related]

  • 16. Biliary pharmacokinetics of sulbactam plus ampicillin in humans.
    Morris DL, Ubhi CS, Robertson CS, Brammer KW.
    Rev Infect Dis; 1986 May; 8 Suppl 5():S589-92. PubMed ID: 3026008
    [Abstract] [Full Text] [Related]

  • 17. [Comprehensive evaluation of pharmacokinetic and clinical studies on tazobactam/piperacillin in pediatric field].
    Fujii R, Okuno A, Fujita K, Yoshikawa M, Inyaku F, Takimoto M, Saijo M, Wagatsuma S, Fukushima N, Ishikawa A.
    Jpn J Antibiot; 1995 Mar; 48(3):311-45. PubMed ID: 7752448
    [Abstract] [Full Text] [Related]

  • 18. High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.
    Augey V, Grosse PY, Albert G, Audran M, Bressolle F.
    J Chromatogr B Biomed Appl; 1996 Jun 28; 682(1):125-36. PubMed ID: 8832433
    [Abstract] [Full Text] [Related]

  • 19. Comparative pharmacokinetic and pharmacodynamic profile of piperacillin/tazobactam 3.375G Q4H and 4.5G Q6H.
    Mattoes HM, Capitano B, Kim MK, Xuan D, Quintiliani R, Nightingale CH, Nicolau DP.
    Chemotherapy; 2002 May 28; 48(2):59-63. PubMed ID: 12011536
    [Abstract] [Full Text] [Related]

  • 20. Biliary concentrations of piperacillin in patients undergoing cholecystectomy.
    Giron JA, Meyers BR, Hirschman SZ.
    Antimicrob Agents Chemother; 1981 Feb 28; 19(2):309-11. PubMed ID: 6214990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.